LataMed AI Corp.

As of June 30, 2026, LataMed AI Corp. carries a market capitalization of 205.45M, placing it among publicly traded companies globally. Its enterprise value stands at 205.93M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, LataMed AI Corp. has 280.67M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, LataMed AI Corp. maintains a current ratio of - -, meaning it holds the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.78, indicating elevated leverage, while an interest coverage ratio of -6.82 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -7.52, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 13.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, LataMed AI Corp.'s stock has declined approximately 64.18% over the past 52 weeks. The 50-day moving average sits at 0.25, while the 200-day moving average is 2.76.

Over the twelve months ended June 30, 2026, LataMed AI Corp. generated - - in revenue and converted that into -294,069.00 in net income, yielding earnings per share of 0.00. EBITDA reached -256,460.00, while operating income came in at -256,460.00.

As of June 30, 2026, LataMed AI Corp. holds - - in cash and equivalents against 478,355.00 in total debt, resulting in a net debt position of 478,355.00. Total book value stands at 7.05M, with working capital of -771,081.00 providing operational flexibility.

LataMed AI Corp. produced -255,340.00 in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.17: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.12, meaning LataMed AI Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

LataMed AI Corp.'s most recent stock split took place on July 15, 2026 with a 1:5 split ratio.